International AIDS Vaccine Initiative, GlycoMimetics, Inc., and Glycosensors and Diagnostics Collaborate to Develop Novel AIDS Vaccine Candidate
Published: May 09, 2012
NEW YORK & GAITHERSBURG, Md. & ATHENS, Ga.--(BUSINESS WIRE)--The International AIDS Vaccine Initiative (IAVI), GlycoMimetics, Inc. (GMI), and Glycosensors and Diagnostics, LLC (G&D) today announced a collaboration to develop an AIDS vaccine using novel compounds that mimic carbohydrates, called glycomimetics. The project will be funded by IAVI’s Innovation Fund, a program launched to support the application of novel and unconventional technologies to AIDS vaccine design and development.